Literature DB >> 29934698

Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.

Christina Ling1,2, Michael Gavin3,4, Joshua Hanson5, Denis M McCarthy3,4.   

Abstract

Entities:  

Keywords:  Autoimmune hepatitis; Certolizumab pegol; Cholestasis; DILI; Drug-induced liver injury; Duodenal ulcer; Proximal small bowel Crohn’s disease; TNF-α inhibitor drug-induced liver injury

Mesh:

Substances:

Year:  2018        PMID: 29934698     DOI: 10.1007/s10620-018-5135-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  21 in total

Review 1.  Proximal Crohn's disease: review of the clinicopathologic features and therapy.

Authors:  R A van Hogezand; A M Witte; R A Veenendaal; M J Wagtmans; C B Lamers
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

2.  Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents.

Authors:  Cumali Efe; Tugrul Purnak; Ersan Ozaslan; Staffan Wahlin
Journal:  Hepatology       Date:  2010-07-16       Impact factor: 17.425

3.  Phenotype at diagnosis predicts recurrence rates in Crohn's disease.

Authors:  F L Wolters; M G Russel; J Sijbrandij; T Ambergen; S Odes; L Riis; E Langholz; P Politi; A Qasim; I Koutroubakis; E Tsianos; S Vermeire; J Freitas; G van Zeijl; O Hoie; T Bernklev; M Beltrami; D Rodriguez; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

4.  New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease.

Authors:  E Shelton; K Chaudrey; J Sauk; H Khalili; R Masia; D D Nguyen; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2015-03-10       Impact factor: 8.171

5.  Crohn's Disease: Hard to Swallow!

Authors:  Nina Nandy; Michael Gavin; David Martin; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2017-09-07       Impact factor: 3.199

Review 6.  Oral and upper gastrointestinal Crohn's disease.

Authors:  Robyn Laube; Ken Liu; Mark Schifter; Jessica L Yang; Michael K Suen; Rupert W Leong
Journal:  J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 4.029

Review 7.  Duodenal Crohn's Disease.

Authors:  Amy L Lightner
Journal:  Inflamm Bowel Dis       Date:  2018-02-15       Impact factor: 5.325

8.  Capsule endoscopy is superior to small-bowel follow-through and equivalent to ileocolonoscopy in suspected Crohn's disease.

Authors:  Jonathan A Leighton; Ian M Gralnek; Stanley A Cohen; Ervin Toth; David R Cave; Douglas C Wolf; Gerard E Mullin; Scott R Ketover; Peter E Legnani; Ernest G Seidman; Michael D Crowell; Ari J Bergwerk; Ravit Peled; Rami Eliakim
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-27       Impact factor: 11.382

9.  Crohn's disease with gastroduodenal involvement: Diagnostic approach.

Authors:  Sachin B Ingle; Baban D Adgaonkar; Nawab P Jamadar; Saleha Siddiqui; Chitra R Hinge
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

Review 10.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

View more
  2 in total

Review 1.  Hepatobiliary manifestations in inflammatory bowel disease: A practical approach.

Authors:  Paulina Núñez F; Fabiola Castro; Gabriel Mezzano; Rodrigo Quera; Diego Diaz; Lorena Castro
Journal:  World J Hepatol       Date:  2022-02-27

2.  Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.

Authors:  Giuseppe Marrone; Francesco Galati; Marco Biolato; Cristopher Oddy; Sara De Carolis; Angelo Zoli; Antonio Grieco
Journal:  BMC Gastroenterol       Date:  2021-08-06       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.